Education
About Us
Working with TipRanks
Follow Us
Viking Therapeutics (DE:1VT)
NASDAQ:1VT
Viking Therapeutics (1VT) Ownership Overview
2.83% Insiders
17.63%
Mutual Funds
9.19% Other Institutional Investors
12.75% ETFs
57.61% Public Companies and
Individual Investors
The ownership structure of Viking Therapeutics (DE:1VT) stock is a mix of institutional, retail, and individual investors. Approximately 39.57% of the company’s stock is owned by Institutional Investors, 2.83% is owned by Insiders, and 57.61% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 28, 2025 | xxxxxxxxxxxxx | $216475 | |
Oct 28, 2025 | xxxxxxxxxxxxx | $2134200 | |
Oct 28, 2025 | xxxxxxxxxxxxx | $1364615 | |
Oct 28, 2025 | xxxxxxxxxxxxx | $216475 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2025 | xxxxxxxxxxxxx | $553982 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $2775089 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $3245343 | |
Sep 30, 2025 | xxxxxxxxxxxxx | $7936402 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,929,289 | Institution | 7.90% | 324,222,484 | |
| 8,539,320 | Institution | 7.55% | 310,062,709 | |
| 2,755,465 | Institution | 2.44% | 100,050,934 | |
| 2,419,109 | Insider | 2.14% | 87,837,848 | |
| 1,456,707 | Institution | 1.29% | 52,893,031 | |
| 1,358,858 | Institution | 1.20% | 49,340,134 | |
| 1,269,070 | Institution | 1.12% | 46,079,932 | |
| 1,262,263 | Institution | 1.12% | 45,832,770 | |
| 1,176,957 | Institution | 1.04% | 42,735,309 | |
| 986,987 | Institution | 0.87% | 35,837,498 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,539,320 | Institution | 7.55% | 310,062,709 | |
| 1,358,858 | Institution | 1.20% | 49,340,134 | |
| 1,269,070 | Institution | 1.12% | 46,079,932 | |
| 1,262,263 | Institution | 1.12% | 45,832,770 | |
| 1,176,957 | Institution | 1.04% | 42,735,309 | |
| 986,987 | Institution | 0.87% | 35,837,498 | |
| 812,796 | Institution | 0.72% | 29,512,623 | |
| 666,335 | Institution | 0.59% | 24,194,624 | |
| 550,219 | Institution | 0.49% | 19,978,452 | |
| 517,945 | Institution | 0.46% | 18,806,583 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Viking Therapeutics (DE:1VT)?
According to the latest TipRanks data, approximately 9.19% of the company's stock is held by institutional investors, 2.83% is held by insiders, and 57.61% is held by retail investors.
What percentage of Viking Therapeutics (DE:1VT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.19% of Viking Therapeutics (DE:1VT) stock is held by institutional investors.
What percentage of Viking Therapeutics (DE:1VT) stock is held by retail investors?
According to the latest TipRanks data, approximately 57.61% of Viking Therapeutics (DE:1VT) stock is held by retail investors.
Who owns the most shares of Viking Therapeutics (DE:1VT)?
Vanguard owns the most shares of Viking Therapeutics (DE:1VT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.